Aldesleukin Terminated Phase 1 / 2 Trials for Metastatic Cancers / Ovarian / Mesothelioma / Lung Cancers / Cervical Cancers / Malignant Neoplasm of Pancreas / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00923806Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer
NCT00569296Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer